Please provide your email address to receive an email when new articles are posted on . Hagop Kantarjian, MD, received Society of Hematologic Oncology’s Emil J Freireich Distinguished Pioneer Award.

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

Women diagnosed with hematological malignancies during pregnancy face higher severe maternal morbidity and obstetric complications compared to post-pregnancy diagnoses. The study analyzed data from ...

Lenalidomide (Revlimid)-induced second primary malignancies appear to be limited to patients with multiple myeloma, according to a systematic review and meta-analysis. While there was no significant ...

Skysona will now only be indicated for patients without an available HLA-matched allogeneic hematopoietic stem cell donor. The Food and Drug Administration (FDA) has approved new safety labeling ...

SEATTLE — April 30, 2018 — The clinic is staffed by a hematologist, medical geneticist, genetic counselor, and a hematology nurse. SCCA is one of only a few cancer centers in the nation to offer this ...

A recent study suggests that monitoring anxiety and distress levels during watch-and-wait disease management time frames may improve the patient experience. The management of chronic blood cancers ...

One in 10 childhood blood cancers may result from medical imaging-associated radiation exposure. Cancer risk increased with cumulative radiation dose, ranging from 1.41 times higher to 3.59 times ...

Patients with Sjögren disease (SjD) had a 68% higher risk for overall malignancy than the general population, with hematologic malignancies contributing more to this elevated risk than solid tumors.